In Print
Photo by Graham Ramsay
From Focus:
Angiogenesis
Inhibitor Sets Up Deadly Brain Tumors for Therapeutic Blow
A few years ago, Rakesh Jain (pictured) suggested that angiogenesis inhibitors
could help other cancer therapies work better by repairing the blood vessels
around tumors and making them easier to access with chemotherapy and radiation.
A recent study offers evidence for Jain’s predictions. He teamed up with
Tracy Batchelor and Gregory Sorensen for a clinical trial of an angiogenesis
inhibitor in patients with recurrent brain tumors. The first results suggest
that angiogenesis inhibitors can, indeed, be used to normalize a tumor’s
environment, increasing its vulnerability to other therapies.
Upcoming
Second Year Show
“Joseph Martin and the Amazing Technicolor
White Coat”
Thursday, February 22 through Saturday, February 24
7:30–9 p.m.
|
|
Spotlight
Invitational
Awards Announced
Each year, several foundations invite a limited number of HMS
junior faculty and postdocs to apply for their fellowships, but
potential candidates must enter the competition through the HMS
Faculty Fellowship Program. Updated information on the program,
the fellowships, and the application process is available online.
Student Scene
Photo by Jeff Cleary
Weak Links in the Chain of Care
According to Tarayn Fairlie, ancillary duties like paperwork and prescription
refills weigh too heavily on the care provided by primary physicians.
Now an intern, she says she’s steering away from primary care
for just this reason.
Lab Works
A multimedia site featuring Harvard
Medical research.
StudenTalk
Personal takes on issues inside and
outside the classroom. |
